Related Experiment Videos
[Y402H polymorphism in complement factor H and age-related macula degeneration (AMD)].
H P N Scholl1, B H F Weber, M M Nöthen
1Augenklinik, Universität, Bonn. hendrik.scholl@ukb.uni-bonn.de
Summary
Age-related macular degeneration (AMD) is a significant genetic disorder. A specific gene variant, Y402H in complement factor H (CFH), greatly increases AMD risk, accounting for substantial genetic predisposition.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Age-related macular degeneration (AMD) is a complex genetic disorder with a substantial genetic component.
- Genetic risk factors significantly contribute to the development of late-stage AMD, estimated at over two-thirds.
- Identifying molecular-level genetic risk factors is crucial for understanding AMD pathogenesis.
Purpose of the Study:
- To review and summarize findings from molecular genetic studies on AMD.
- To highlight recent discoveries concerning the complement factor H (CFH) gene in AMD.
- To emphasize the role of specific genetic polymorphisms in AMD susceptibility.
Main Methods:
- Review of comprehensive genetic studies including candidate gene approaches.
- Analysis of linkage and association studies in AMD research.
- Focus on recent data from molecular genetic investigations of the CFH gene.
Main Results:
- A significant risk allele, Y402H, has been identified in the complement factor H (CFH) gene.
- The Y402H polymorphism is associated with a 2.4-7.4 fold increased relative risk of developing AMD.
- This specific polymorphism explains approximately 20-50% of the overall genetic risk for AMD.
Conclusions:
- The complement factor H (CFH) gene and its Y402H polymorphism are major genetic determinants of AMD.
- Molecular genetic studies have successfully identified key risk factors at the molecular level.
- Understanding these genetic factors is vital for future research and potential therapeutic strategies for AMD.